Regeneron Pharmaceuticals
Regeneron is seeking multiple 2027 Co-ops to join the Preclinical Manufacturing and Process Development team, where they will help develop manufacturing processes to scale up and produce life-changing medicines. This full-time, onsite role offers students the opportunity to contribute to a science-driven organization making a meaningful difference for patients worldwide. Participants will work on purification techniques, analytical method development, and process improvement during the Spring-Summer, Summer-Fall, or Fall co-op terms.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Summer-Fall 2026 Co-Op - Recombinant Mammalian MSAT Downstream
Sanofi
Downstream Purification Scientist
Global Channel Management
Scientist I , Purification Process Development
Evotec
Scientist, mRNA Downstream Purification
NewLimit
Manufacturing Associate Downstream
avidbio
Research Associate Co-op, Downstream Process Development
WuXi Biologics